Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04106219
Title A Study of LY3295668 Erbumine in Participants With Relapsed/Refractory Neuroblastoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: child | adult
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | BEL | AUS

Facility Status City State Zip Country Details
UCSF Medical Center at Mission Bay San Francisco California 94158 United States Details
Children's Hospital Colorado Aurora Colorado 80045 United States Details
University of Chicago - Comer Children's Hospital Chicago Illinois 60637 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02115 United States Details
Cincinnati Childrens Hospital Medical Center Cincinnati Ohio 45229 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 United States Details
Texas Childrens Hospital Houston Texas 77030 United States Details
Perth Children's Hospital Perth Western Australia 6009 Australia Details
UZ Gent Gent Oost-Vlaanderen 9000 Belgium Details
Centre Leon Berard Lyon Rhône-Alpes 69373 CEDEX 08 France Details
Institut Curie Paris CEDEX 05 75248 France Details
Universitätsklinikum Köln Köln 50924 Germany Details
Istituto Nazionale dei Tumori Milano Lombardie 20133 Italy Details
National Cancer Center Hospital Chuo-ku Tokyo 104-0045 Japan Details
Hospital Universitari Vall d'Hebron Barcelona Barcelona [Barcelona] 8035 Spain Details
Hospital Infantil Universitario Niño Jesús Madrid 28009 Spain Details
Alder Hey Children's Hospital Liverpool L14 5AB United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field